Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (23601)	7/27/1998 9:22:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

I guess the 'market' never buys based on future earings. Have you looked at YHOO lately? The 'street' know about the projections. You are ignoring both risk and further dilution.

To: Andreas Helke who wrote (23601)	7/27/1998 9:34:00 PM
From: Henry Niman	Respond to of 32384

Andreas, LGND's future projections are quite enticing. I actually thought they they were rather conservative. Of course, 2006 is still many years away and such projections are difficult to make accurately. However, LGND's pipeline is extremely impressive, and it is quite a bit larger and more mature than in was in 1996 when the BARS projections were made. More recent projections do show that the numbers put out in 1996 were conservative. At that time, a profit for LGND was projected for 2000 ($0.10), while most recent estimates project similar positive earnings a year earlier (next year). Profits from the earlier products can accelerate development quite markedly. It will be interesting to see how far and fast development actually occurs.